PARP1 and Parkinson disease: Moreover, modulating the activity of NAD+-consuming enzyme, such as by PARP inhibition or mutation, restores NAD+ levels and rescues mitochondrial dysfunction in cell and Drosophila models of PD (Lehmann et al., 2016; 2017; Delgado-Camprubi et al., 2017).